Search
Leptazoline A
go.drugbank.com/drugs/DB15551ExperimentalLeptazoline A is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].
Synonyms: Leptazoline ALeptazoline B
go.drugbank.com/drugs/DB15552ExperimentalLeptazoline B is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].
Leptazoline C
go.drugbank.com/drugs/DB15553ExperimentalLeptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].
Reloxaliase
go.drugbank.com/drugs/DB15560InvestigationalReloxaliase is a crystalline formulation of oxalate decarboxylase derived from _Bacillus Subtilis_.
FLX475
go.drugbank.com/drugs/DB15570InvestigationalFLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875]
Echinomycin
go.drugbank.com/drugs/DB15582ExperimentalEchinomycin is a cytotoxic polypeptide quinoxaline antibiotic isolated from _Streptomyces echinatus_ that binds to DNA and inhibits RNA synthesis.
Synonyms: Quinomycin AFluzoparib
go.drugbank.com/drugs/DB15637InvestigationalFluzoparib is under investigation in clinical trial NCT03863860 (A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients).
Gusacitinib
go.drugbank.com/drugs/DB15670InvestigationalGusacitinib is under investigation in clinical trial NCT02550678 (A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma).
Synonyms: 1-(4-(4-(4-HYDROXY-PIPERIDIN-1-YL)-PHENYLAMINO)-5-OXO-5,6-DIHYDRO-PYRIMIDO(4,5-D)PYRIDAZIN-2-YL)-PIPERIDIN-4-YL-ACETONITRILENeisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen
go.drugbank.com/drugs/DB15682ApprovedInvestigational